Esperion Therapeutics, Inc. ( ESPR) - Key Metrics
ESPR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.71 | $0.26 | $0.19 | $0.19 |
| 2025Q3 | $0.44 | -$0.16 | -$0.02 | -$0.02 |
| 2025Q2 | $0.42 | -$0.06 | -$0.16 | -$0.16 |
| 2025Q1 | $0.33 | -$0.21 | -$0.12 | -$0.12 |
ESPR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 3.54 |
| 2025Q3 | ? | -4.19 |
| 2025Q2 | ? | -3.81 |
| 2025Q1 | ? | -1.75 |
ESPR
Price: $3.13
52 week price:
Earnings Per Share: -0.11 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 623424
Ebitda: -37.8 millionMarket Capitalization: 805.8 million